Please assess the completion status of the following clinical trial:

Trial Title: A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with active Crohn's disease~* Patients who have a primary lesion in either the small intestine or the large intestine~* Patients who have been receiving an oral 5-ASA formulation at a fixed regimen and at a fixed dose~* Patients who have either never received enteral nutrition or have been receiving enteral nutrition at a fixed intake of 1200 kcal/day or less~* Either inpatient or outpatient~Exclusion Criteria:~* Patients who have an external fistula (including anal fistula) in which persistent drainage is observed (and who require treatment with antibiotics or synthetic antibacterial agents)~* Patients with short bowel syndrome (and who require intravenous nutritional support due to insufficient intestinal nutrient uptake)~* Patients with an artificial anus~* Patients who have a complication of serious infectious disease (intra-abdominal abscess, etc.)~* Patients who have a complication of malignant tumor~* Female patients who are pregnant, lactating, or possibly pregnant, or who wish to become pregnant during the study period

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).